Easton Capital

WellTrackONE, LLC is a population health management company based in Hilton Head Island, South Carolina, with an additional location in New York, New York. Established in 2010, the company provides wellness programs designed for healthcare providers and organizations across the United States. Its services include managing annual wellness visits for Medicare patients, supplying critical data for accountable care organizations, and assisting healthcare systems in meeting clinical indicators and quality measures. WellTrackONE also offers customized wellness solutions for commercial organizations and delivers clinical risk management services that generate comprehensive baseline reports detailing modifiable risk factors and preventative goals. By streamlining scheduling, screening, and documentation processes, WellTrackONE enables healthcare professionals to enhance patient care and improve revenue generation while ensuring compliance with healthcare standards.

Claret Medical, Inc. is a cardiovascular medical device company based in Santa Rosa, California, focused on developing cerebral vascular protection systems for transcatheter aortic valve implantation and other endovascular procedures. The company's flagship product, the Claret Medical Sentinel Cerebral Protection System, is a percutaneously delivered embolic protection device designed to capture and remove debris dislodged during these procedures, thereby reducing the risk of stroke. Additionally, Claret Medical offers small 6 French catheters that are inserted through an artery into the patient's right arm, guiding the system to the heart and effectively safeguarding the brain from embolic material during interventional procedures. Incorporated in 2009, Claret Medical aims to enhance patient safety and outcomes by preventing the entry of thrombus and debris into the cerebral vascular system during various cardiovascular interventions.

Bluesight operates as a healthcare technology company specializing in supply chain optimization for pharmaceuticals. It offers Medication Intelligence solutions that provide real-time analytics across the entire medication lifecycle, enhancing efficiency, reducing risks, and improving patient safety within hospitals. The core product is an inventory management platform that automates pharmacy kit processing and medication tracking, replacing manual processes to increase operational efficiency and medication visibility.

WellTrackONE, LLC is a population health management company based in Hilton Head Island, South Carolina, with an additional location in New York, New York. Established in 2010, the company provides wellness programs designed for healthcare providers and organizations across the United States. Its services include managing annual wellness visits for Medicare patients, supplying critical data for accountable care organizations, and assisting healthcare systems in meeting clinical indicators and quality measures. WellTrackONE also offers customized wellness solutions for commercial organizations and delivers clinical risk management services that generate comprehensive baseline reports detailing modifiable risk factors and preventative goals. By streamlining scheduling, screening, and documentation processes, WellTrackONE enables healthcare professionals to enhance patient care and improve revenue generation while ensuring compliance with healthcare standards.

Founded in 2012, Wildflower Health is a San Francisco-based company that specializes in smartphone-based health programs. It offers Due Date Plus for maternity care and GROW for family health, providing services such as reminders, provider look-up, and health risk assessments to support users and connect them with healthcare providers.

PerceptiMed, Inc. is a technology company based in Mountain View, California, specializing in medication verification systems designed to minimize human errors in medication dispensing across pharmacies, long-term care facilities, and hospitals. Founded in 2011, the company offers a range of products, including the IdentRx automated medication-verification device, which ensures accurate prescription pill verification and administration. Complementing this device is IdentRx Remote, software that facilitates remote verification of dispensed pills, and MedPass, a system aimed at preventing errors in pill administration. Additionally, PerceptiMed provides ScripClip, an electronic tagging system to enhance medication management. The company's innovative VeriFill technology ensures 100% verification of drug, dosage, and manufacturer for each pill dispensed, positioning PerceptiMed as a leader in the healthcare technology sector.

Bluesight operates as a healthcare technology company specializing in supply chain optimization for pharmaceuticals. It offers Medication Intelligence solutions that provide real-time analytics across the entire medication lifecycle, enhancing efficiency, reducing risks, and improving patient safety within hospitals. The core product is an inventory management platform that automates pharmacy kit processing and medication tracking, replacing manual processes to increase operational efficiency and medication visibility.

Medikly, Inc. is a Jersey City-based company founded in 2009 that specializes in providing a digital marketing platform tailored for healthcare marketers. This platform allows marketers to capture and utilize actionable insights about physicians, facilitating deeper engagement and understanding. MediklyOS, the company's key offering, enables brands to launch, execute, modify, and measure marketing campaigns effectively. By connecting healthcare marketers with physicians across various digital channels, Medikly empowers pharmaceutical brands to establish individual relationships with healthcare professionals. In addition to its platform, the company also offers consulting, support, training, integration, and campaign services to enhance marketing effectiveness and drive business value.

Claret Medical, Inc. is a cardiovascular medical device company based in Santa Rosa, California, focused on developing cerebral vascular protection systems for transcatheter aortic valve implantation and other endovascular procedures. The company's flagship product, the Claret Medical Sentinel Cerebral Protection System, is a percutaneously delivered embolic protection device designed to capture and remove debris dislodged during these procedures, thereby reducing the risk of stroke. Additionally, Claret Medical offers small 6 French catheters that are inserted through an artery into the patient's right arm, guiding the system to the heart and effectively safeguarding the brain from embolic material during interventional procedures. Incorporated in 2009, Claret Medical aims to enhance patient safety and outcomes by preventing the entry of thrombus and debris into the cerebral vascular system during various cardiovascular interventions.

electroCore is a commercial-stage medical device company focused on non-invasive vagus nerve stimulation (nVNS) therapies. Its gammaCore platform provides prescription-only nVNS treatments for acute migraine and episodic cluster headache in adults and for preventive management of cluster headache and migraine. The company offers gammaCore Sapphire, a rechargeable handheld device designed for multi-year use with monthly prescriptions. The platform aims to address neurology-related conditions by providing non-invasive neuromodulation alternatives, with FDA-cleared indications for several adult-use conditions and expanding use in adolescents.

Founded in 2008, medCPU develops real-time enterprise decision support software for hospitals in the United States. Its core product, medCPU Advisor, integrates with electronic medical records to analyze both structured and unstructured data, generating precise prompts for clinical care consideration.

Respiratory Motion, Inc. is a medical device company headquartered in Waltham, Massachusetts, that specializes in respiratory monitoring systems. Established in 2011, the company focuses on the development and commercialization of innovative devices designed to monitor respiratory variation and vital respiratory parameters. Its flagship product, ExSpiron, is a point-of-care device that non-invasively measures minute ventilation, tidal volume, and respiratory rate, providing physicians with critical data to enhance patient safety and outcomes. Respiratory Motion's technology enables continuous monitoring across diverse patient populations and clinical environments, offering early warnings of potential respiratory collapse. The company's systems have received FDA clearance, underscoring their commitment to advancing respiratory health care.

TigerConnect is a leading provider of secure, real-time communication solutions in healthcare. Its platform facilitates teamwork among doctors, nurses, patients, and care providers through text, video, and voice communication. Trusted by over 4,000 organizations, TigerConnect maintains high uptime and processes millions of messages daily. Headquartered in Santa Monica, California, the company was founded in 2010.

SOLX Inc., established in 2000 and based in Waltham, Massachusetts, specializes in developing medical devices for glaucoma treatment. Its primary product is the SOLX Gold Shunt, a minimally invasive device used in glaucoma surgery to manage intraocular pressure (IOP).

Precise Light Surgical, Inc. is a company that specializes in developing innovative tissue resection solutions for microsurgical procedures. Founded in 2008 and headquartered in California, it focuses on providing less invasive surgical options that preserve critical anatomy, thereby reducing surgical risks and improving patient outcomes. The company’s technology employs flash vaporization, enabling unprecedented precision and control in the removal of delicate tissues while sparing nerves and vessels. This approach is applicable in various surgical fields, including plastic surgery, ear, nose, and throat (ENT) surgery, and neurosurgery. By enhancing surgical accuracy and minimizing downtime, Precise Light Surgical aims to improve the overall efficiency and safety of surgical procedures.

Comprehend Systems, Inc. is a Redwood City, California-based company that specializes in cloud-based continuous quality solutions for clinical operations. Founded in 2010, the company offers a comprehensive suite of clinical intelligence applications designed to enhance the efficiency, safety, and quality of clinical trials. These applications cater to clinical operations executives, data managers, and medical monitors, providing tools for portfolio monitoring, continuous quality assessment, collaboration with contract research organizations (CROs), and risk and medical monitoring. Comprehend Systems aims to deliver actionable insights across studies, systems, sites, and vendors, thereby improving the overall clinical trial process. In 2019, it became a subsidiary of Saama Technologies, Inc.

Bluesight operates as a healthcare technology company specializing in supply chain optimization for pharmaceuticals. It offers Medication Intelligence solutions that provide real-time analytics across the entire medication lifecycle, enhancing efficiency, reducing risks, and improving patient safety within hospitals. The core product is an inventory management platform that automates pharmacy kit processing and medication tracking, replacing manual processes to increase operational efficiency and medication visibility.

Medikly, Inc. is a Jersey City-based company founded in 2009 that specializes in providing a digital marketing platform tailored for healthcare marketers. This platform allows marketers to capture and utilize actionable insights about physicians, facilitating deeper engagement and understanding. MediklyOS, the company's key offering, enables brands to launch, execute, modify, and measure marketing campaigns effectively. By connecting healthcare marketers with physicians across various digital channels, Medikly empowers pharmaceutical brands to establish individual relationships with healthcare professionals. In addition to its platform, the company also offers consulting, support, training, integration, and campaign services to enhance marketing effectiveness and drive business value.

Within3, Inc. is a digital collaboration solutions provider focused on the healthcare, pharmaceutical, and life sciences sectors. Established in 2004 and headquartered in Lakewood, Ohio, with an additional location in the United Kingdom, the company specializes in facilitating engagement among healthcare professionals worldwide. Its technology supports various initiatives, including virtual advisory boards, steering committees, clinical trial design and operations, and internal training programs. Within3's platform allows organizations to engage physicians, nurses, payers, and patients in a compliant manner, utilizing social technologies to create private, regulatory-compliant environments for collaboration. The company aims to enhance the interaction and collaboration within the healthcare ecosystem to improve outcomes and streamline processes.

PerceptiMed, Inc. is a technology company based in Mountain View, California, specializing in medication verification systems designed to minimize human errors in medication dispensing across pharmacies, long-term care facilities, and hospitals. Founded in 2011, the company offers a range of products, including the IdentRx automated medication-verification device, which ensures accurate prescription pill verification and administration. Complementing this device is IdentRx Remote, software that facilitates remote verification of dispensed pills, and MedPass, a system aimed at preventing errors in pill administration. Additionally, PerceptiMed provides ScripClip, an electronic tagging system to enhance medication management. The company's innovative VeriFill technology ensures 100% verification of drug, dosage, and manufacturer for each pill dispensed, positioning PerceptiMed as a leader in the healthcare technology sector.

Resolve Therapeutics, LLC is a clinical-stage biopharmaceutical company based in Seattle, Washington, focused on developing innovative biological therapies for autoimmune diseases, particularly systemic lupus erythematosus and Sjögren's syndrome. The company is advancing its lead product candidates, RSLV-132 and RSLV-133, which are designed to target and degrade immune complexes that contribute to disease pathology. RSLV-132 is a mono-specific nuclease Fc-fusion protein aimed at preventing interferon activation and mitigating kidney damage, while RSLV-133 combines two different nuclease activities into a single therapeutic molecule. Founded in 2010, Resolve Therapeutics is rooted in pioneering research from the University of Washington School of Medicine, with a commitment to improving the lives of patients suffering from these chronic conditions.

Promedior, Inc. is a clinical-stage biotechnology company based in Lexington, Massachusetts, focused on developing innovative therapeutics for rare fibrotic diseases and retinal fibrovascular conditions. The company targets conditions such as myelofibrosis, idiopathic pulmonary fibrosis, age-related macular degeneration, and diabetic retinopathy. Promedior's portfolio includes PRM-151, a recombinant form of human pentaxin-2 protein designed for intravenous injection, and PRM-167, a variant formulated for intravitreal delivery. Promedior employs a novel drug discovery platform that aims to regulate monocyte-derived cell populations, which are critical in inflammatory, fibrotic, and autoimmune diseases. By specifically addressing these cells at the injury site, Promedior seeks to treat the underlying causes of immune system dysregulation, promote tissue healing, and minimize systemic side effects associated with traditional therapies. The company's commitment to addressing severe and challenging conditions positions it as a significant player in the biopharmaceutical landscape.

Achronix Semiconductor Corp. is a privately held fabless semiconductor company based in Santa Clara, California, specializing in the development of high-density and high-performance application-targeted field programmable gate arrays (FPGAs). Its flagship product line, Speedster22i, utilizes Intel's advanced 22nm process technology and integrates hard IP protocol functions tailored for communications applications. Achronix also provides Speedcore eFPGA IP for integration into customers' system-on-chips (SoCs) aimed at compute and network acceleration. The company offers a robust design-tool suite known as the Achronix CAD Environment (ACE), which supports industry-standard synthesis tools. Achronix serves a variety of markets, including networking, optical/telecom, high-performance computing, test and measurement, and military and security. Founded in 2004, Achronix distributes its products through a network that spans North America, Europe, Israel, China, and Russia, with additional research and development facilities located in Bangalore, India.

Promedior, Inc. is a clinical-stage biotechnology company based in Lexington, Massachusetts, focused on developing innovative therapeutics for rare fibrotic diseases and retinal fibrovascular conditions. The company targets conditions such as myelofibrosis, idiopathic pulmonary fibrosis, age-related macular degeneration, and diabetic retinopathy. Promedior's portfolio includes PRM-151, a recombinant form of human pentaxin-2 protein designed for intravenous injection, and PRM-167, a variant formulated for intravitreal delivery. Promedior employs a novel drug discovery platform that aims to regulate monocyte-derived cell populations, which are critical in inflammatory, fibrotic, and autoimmune diseases. By specifically addressing these cells at the injury site, Promedior seeks to treat the underlying causes of immune system dysregulation, promote tissue healing, and minimize systemic side effects associated with traditional therapies. The company's commitment to addressing severe and challenging conditions positions it as a significant player in the biopharmaceutical landscape.

TigerConnect is a leading provider of secure, real-time communication solutions in healthcare. Its platform facilitates teamwork among doctors, nurses, patients, and care providers through text, video, and voice communication. Trusted by over 4,000 organizations, TigerConnect maintains high uptime and processes millions of messages daily. Headquartered in Santa Monica, California, the company was founded in 2010.

SOLX Inc., established in 2000 and based in Waltham, Massachusetts, specializes in developing medical devices for glaucoma treatment. Its primary product is the SOLX Gold Shunt, a minimally invasive device used in glaucoma surgery to manage intraocular pressure (IOP).

Within3, Inc. is a digital collaboration solutions provider focused on the healthcare, pharmaceutical, and life sciences sectors. Established in 2004 and headquartered in Lakewood, Ohio, with an additional location in the United Kingdom, the company specializes in facilitating engagement among healthcare professionals worldwide. Its technology supports various initiatives, including virtual advisory boards, steering committees, clinical trial design and operations, and internal training programs. Within3's platform allows organizations to engage physicians, nurses, payers, and patients in a compliant manner, utilizing social technologies to create private, regulatory-compliant environments for collaboration. The company aims to enhance the interaction and collaboration within the healthcare ecosystem to improve outcomes and streamline processes.

EMKinetics, Inc. is a clinical-stage medical technology company based in San Francisco, California, that specializes in developing neuromodulation therapies using its proprietary Transdermal Stimulation (TranStim) technology. The company focuses on innovative treatments for conditions such as overactive bladder and other related ailments, employing electric pulses to prevent urinary incontinence. Founded in 2006, EMKinetics is dedicated to advancing its therapeutic offerings through cutting-edge research and development in the field of neuromodulation.

Resolve Therapeutics, LLC is a clinical-stage biopharmaceutical company based in Seattle, Washington, focused on developing innovative biological therapies for autoimmune diseases, particularly systemic lupus erythematosus and Sjögren's syndrome. The company is advancing its lead product candidates, RSLV-132 and RSLV-133, which are designed to target and degrade immune complexes that contribute to disease pathology. RSLV-132 is a mono-specific nuclease Fc-fusion protein aimed at preventing interferon activation and mitigating kidney damage, while RSLV-133 combines two different nuclease activities into a single therapeutic molecule. Founded in 2010, Resolve Therapeutics is rooted in pioneering research from the University of Washington School of Medicine, with a commitment to improving the lives of patients suffering from these chronic conditions.

Bluebird Bio is a clinical-stage biotechnology company focused on developing gene therapies to treat severe genetic and rare diseases. Its proprietary lentiviral vector platform enables the creation of potentially curative treatments by genetically modifying patients' cells to address the root cause of these conditions.

Autonet Mobile, Inc. is a technology company that specializes in Internet-based telematics and applications services aimed at enhancing vehicle connectivity. Founded in 2005 and headquartered in Santa Rosa, California, the company provides a range of products under its Dealer Connect suite, which assists automotive dealers in automating vehicle health scans, tracking inventory, scheduling customer appointments, and offering various applications. Autonet Mobile's platform enables real-time diagnostics, alerts for routine maintenance, and access to WiFi, effectively transforming standard vehicles into connected cars. The company also emphasizes customer support, offering installation and activation services for its solutions. As a subsidiary of Lear Corporation, Autonet Mobile has established partnerships with several major automotive manufacturers, positioning itself at the forefront of the connected vehicle market.

Format Dynamics is a company that specializes in creating new advertising inventory through the optimization of web page printing. By enhancing the way online content is presented, the company transforms printed web pages to resemble magazines, thereby introducing relevant print ad opportunities. Advertisers can connect specific printable information and offers to onscreen advertisements, facilitating a seamless transition from digital to print. Format Dynamics' tools not only improve the user experience but also empower advertisers to craft targeted advertising opportunities, ultimately leading to increased revenue potential.

CardioMEMS is a medical device company specializing in wireless monitoring solutions for severe chronic cardiovascular conditions. Their proprietary technology involves miniature sensors implanted via minimally invasive procedures, transmitting vital data like cardiac output, blood pressure, and heart rate to enhance patient management, particularly for heart failure, hypertension, and aneurysms.

EMKinetics, Inc. is a clinical-stage medical technology company based in San Francisco, California, that specializes in developing neuromodulation therapies using its proprietary Transdermal Stimulation (TranStim) technology. The company focuses on innovative treatments for conditions such as overactive bladder and other related ailments, employing electric pulses to prevent urinary incontinence. Founded in 2006, EMKinetics is dedicated to advancing its therapeutic offerings through cutting-edge research and development in the field of neuromodulation.

Bluebird Bio is a clinical-stage biotechnology company focused on developing gene therapies to treat severe genetic and rare diseases. Its proprietary lentiviral vector platform enables the creation of potentially curative treatments by genetically modifying patients' cells to address the root cause of these conditions.

Coapt Systems, Inc. specializes in the design, development, and manufacture of bio-absorbable implants used in soft tissue fixation during facial cosmetic surgery. The company offers a range of products, including the ENDOTINE Forehead 3.0 and ENDOTINE Triple 3.0, which are designed for brow fixation, along with ENDOTINE Midface ST 4.5 for midface suspension. Other offerings include the ENDOTINE Ribbon and various surgical tools such as manual surgical drills and incisionless dissectors for precise application. Coapt's implants are utilized in procedures like forehead lifts, brow lifts, and midface and neck suspensions, catering to the needs of plastic surgeons in enhancing patient outcomes.

CardioMEMS is a medical device company specializing in wireless monitoring solutions for severe chronic cardiovascular conditions. Their proprietary technology involves miniature sensors implanted via minimally invasive procedures, transmitting vital data like cardiac output, blood pressure, and heart rate to enhance patient management, particularly for heart failure, hypertension, and aneurysms.

PlaySpan is a prominent provider of monetization solutions for online games, virtual worlds, and social networks. The company specializes in developing a digital goods commerce and micropayment platform that enables game publishers and developers to generate revenue, attract new users, and enhance user loyalty. One of its key offerings is UltimatePay, a global payment solution that facilitates safe and convenient in-app purchases through over 85 payment methods across 180 countries. This service includes the Ultimate Game Card, a prepaid card available in more than 45,000 retail locations throughout North America and expanding internationally. Headquartered in Silicon Valley, PlaySpan also operates offices in Ohio, Virginia, and Mumbai. The company has received recognition for its contributions to the gaming industry, winning the 2009 OnHollywood Category Award for Best Gaming Company.

Achronix Semiconductor Corp. is a privately held fabless semiconductor company based in Santa Clara, California, specializing in the development of high-density and high-performance application-targeted field programmable gate arrays (FPGAs). Its flagship product line, Speedster22i, utilizes Intel's advanced 22nm process technology and integrates hard IP protocol functions tailored for communications applications. Achronix also provides Speedcore eFPGA IP for integration into customers' system-on-chips (SoCs) aimed at compute and network acceleration. The company offers a robust design-tool suite known as the Achronix CAD Environment (ACE), which supports industry-standard synthesis tools. Achronix serves a variety of markets, including networking, optical/telecom, high-performance computing, test and measurement, and military and security. Founded in 2004, Achronix distributes its products through a network that spans North America, Europe, Israel, China, and Russia, with additional research and development facilities located in Bangalore, India.

Xoft, Inc. specializes in the development of electronic brachytherapy (eBx) systems designed for radiation oncology applications. The company’s flagship product, the Axxent Controller, employs a miniaturized high dose rate X-ray source to deliver targeted radiation directly to cancerous tumor beds. Xoft also provides a range of applicators, including the Axxent balloon applicator for accelerated partial breast irradiation, the Axxent vaginal applicator for vaginal brachytherapy, and the Axxent surface applicator for treating surface lesions. Additionally, the company offers a variety of accessories to support its products, such as physics accessory kits and protective shields to minimize radiation exposure to healthy tissues. Xoft’s innovative solutions are primarily utilized in the treatment of early-stage breast cancer, skin cancer, and endometrial cancer, and the products are distributed through physicians and distributors across Europe. Founded in 1998 and based in Sunnyvale, California, Xoft was previously known as Xoft microTube, Inc. before rebranding in 2004.

PlaySpan is a prominent provider of monetization solutions for online games, virtual worlds, and social networks. The company specializes in developing a digital goods commerce and micropayment platform that enables game publishers and developers to generate revenue, attract new users, and enhance user loyalty. One of its key offerings is UltimatePay, a global payment solution that facilitates safe and convenient in-app purchases through over 85 payment methods across 180 countries. This service includes the Ultimate Game Card, a prepaid card available in more than 45,000 retail locations throughout North America and expanding internationally. Headquartered in Silicon Valley, PlaySpan also operates offices in Ohio, Virginia, and Mumbai. The company has received recognition for its contributions to the gaming industry, winning the 2009 OnHollywood Category Award for Best Gaming Company.

Transave, Inc., a biotechnology company, develops inhaled pharmaceuticals for the treatment of lung diseases. The company’s liposomal technology allows the release of drug in the lung's microenvironment. Its products also include Arikace for the treatment of gram-negative lung infections and pseudomonas infections in cystic fibrosis patients; and cisplatin lipid complex for the treatment of cancers affecting the lungs. Transave, Inc. was founded in 1997 and is headquartered in Monmouth Junction, New Jersey. As of December 1, 2010, Transave, Inc. operates as a subsidiary of Insmed Incorporated.

WIRECOM Technologies is a French company with state-of-the-art technology and an experience of over 10 years. Committed to sustainable development and the fight against global warming, WIRECOM Technologies designs and develops solutions to optimise energy efficiency in buildings and residences

GoCrossCampus, initially the flagship product of GXStudios, was developed by a group of students from Yale and Columbia between 2007 and 2010. It emerged as a pioneering social gaming platform, engaging hundreds of thousands of college students in a rivalry-based game of territorial conquest. Players formed teams representing different colleges or affinity groups, competing to conquer each other's campuses through strategic gameplay that included real-time interactions and recruitment efforts. The game's popularity extended beyond college campuses, with GXStudios also creating GoCrossOffice, a variant designed for corporate team-building activities aimed at enhancing morale and communication within virtual workforces. Despite its initial success, the company faced challenges during the 2008-2009 recession, leading to the decision to wind down operations and license its intellectual property. The founders were part of the Yale Entrepreneurial Institute, which continues to support startup ventures today.

PlaySpan is a prominent provider of monetization solutions for online games, virtual worlds, and social networks. The company specializes in developing a digital goods commerce and micropayment platform that enables game publishers and developers to generate revenue, attract new users, and enhance user loyalty. One of its key offerings is UltimatePay, a global payment solution that facilitates safe and convenient in-app purchases through over 85 payment methods across 180 countries. This service includes the Ultimate Game Card, a prepaid card available in more than 45,000 retail locations throughout North America and expanding internationally. Headquartered in Silicon Valley, PlaySpan also operates offices in Ohio, Virginia, and Mumbai. The company has received recognition for its contributions to the gaming industry, winning the 2009 OnHollywood Category Award for Best Gaming Company.

IGA Worldwide is a leading provider of in-game advertising technology, specializing in creating impactful advertising experiences within video games. The company operates its proprietary ad serving network, Radial, which offers extensive reach and accountability across major gaming platforms, including PlayStation, PC, Nintendo Wii, and Xbox 360. IGA Worldwide focuses on delivering innovative advertising solutions, such as product placements and branded content, that enhance gameplay without being intrusive. By leveraging its expertise and advanced metrics, the company enables advertisers, developers, and publishers to effectively engage with diverse consumer audiences while they play, positioning itself as a key player in the in-game advertising sector.

Gentis is a developer of biomaterials-based products focused on addressing early-stage degeneration of the spine. Founded in 2000 and headquartered in Wayne, Pennsylvania, the company offers a patented product called DiscCell. This innovative injectable material is designed to augment or replace the diseased nucleus pulposus of the spinal disc. DiscCell is characterized by its in-situ setting, radio-opacity, and non-hydrogel polymer composition, which collectively aim to alleviate back or leg pain and prevent recurrence at the treatment site.

Biolex Therapeutics is a clinical-stage biopharmaceutical company focused on developing therapeutic proteins and monoclonal antibodies using its patented LEX System. This innovative technology genetically transforms the aquatic plant Lemna to facilitate the production of biologic product candidates that are challenging to manufacture. Biolex's primary product is designed to address the needs of patients afflicted with Hepatitis C, aiming to improve treatment outcomes through enhanced efficacy and potency of its therapeutic offerings.

Lamina, a Westhampton, N.J.-based LED developer.

Xoft, Inc. specializes in the development of electronic brachytherapy (eBx) systems designed for radiation oncology applications. The company’s flagship product, the Axxent Controller, employs a miniaturized high dose rate X-ray source to deliver targeted radiation directly to cancerous tumor beds. Xoft also provides a range of applicators, including the Axxent balloon applicator for accelerated partial breast irradiation, the Axxent vaginal applicator for vaginal brachytherapy, and the Axxent surface applicator for treating surface lesions. Additionally, the company offers a variety of accessories to support its products, such as physics accessory kits and protective shields to minimize radiation exposure to healthy tissues. Xoft’s innovative solutions are primarily utilized in the treatment of early-stage breast cancer, skin cancer, and endometrial cancer, and the products are distributed through physicians and distributors across Europe. Founded in 1998 and based in Sunnyvale, California, Xoft was previously known as Xoft microTube, Inc. before rebranding in 2004.

Coapt Systems, Inc. specializes in the design, development, and manufacture of bio-absorbable implants used in soft tissue fixation during facial cosmetic surgery. The company offers a range of products, including the ENDOTINE Forehead 3.0 and ENDOTINE Triple 3.0, which are designed for brow fixation, along with ENDOTINE Midface ST 4.5 for midface suspension. Other offerings include the ENDOTINE Ribbon and various surgical tools such as manual surgical drills and incisionless dissectors for precise application. Coapt's implants are utilized in procedures like forehead lifts, brow lifts, and midface and neck suspensions, catering to the needs of plastic surgeons in enhancing patient outcomes.

Sanarus Medical, Inc. specializes in developing and marketing minimally invasive devices for the diagnosis and treatment of breast tumors. The company offers the Visica Treatment System, which utilizes cryoablation to treat breast fibroadenomas, and the Cassi II rotational core biopsy system, an automated device designed for obtaining contiguous biopsy samples. Additionally, Sanarus provides the ImarC tissue marker system, which includes breast tissue markers visible under various imaging modalities. Founded in 1999 and headquartered in Pleasanton, California, Sanarus Medical focuses on providing innovative solutions for both cancerous and non-cancerous breast conditions.

Trellis Bioscience LLC is a biotechnology company focused on discovering and developing human antibody therapeutics for infectious diseases and oncology. The company utilizes its proprietary CellSpot technology platform to identify and extract rare, naturally optimized antibodies from healthy human donor blood cells. This enables the development of therapeutic monoclonal antibodies targeting various infectious diseases and cancer immune checkpoints. Trellis aims to offer alternatives for patients facing challenges with conventional protein therapeutics, particularly in cases where the immune system may attack these treatments. Founded in 1998, Trellis Bioscience is headquartered in Redwood City, California.

Achronix Semiconductor Corp. is a privately held fabless semiconductor company based in Santa Clara, California, specializing in the development of high-density and high-performance application-targeted field programmable gate arrays (FPGAs). Its flagship product line, Speedster22i, utilizes Intel's advanced 22nm process technology and integrates hard IP protocol functions tailored for communications applications. Achronix also provides Speedcore eFPGA IP for integration into customers' system-on-chips (SoCs) aimed at compute and network acceleration. The company offers a robust design-tool suite known as the Achronix CAD Environment (ACE), which supports industry-standard synthesis tools. Achronix serves a variety of markets, including networking, optical/telecom, high-performance computing, test and measurement, and military and security. Founded in 2004, Achronix distributes its products through a network that spans North America, Europe, Israel, China, and Russia, with additional research and development facilities located in Bangalore, India.

CardioMEMS is a medical device company specializing in wireless monitoring solutions for severe chronic cardiovascular conditions. Their proprietary technology involves miniature sensors implanted via minimally invasive procedures, transmitting vital data like cardiac output, blood pressure, and heart rate to enhance patient management, particularly for heart failure, hypertension, and aneurysms.

Cardiovascular Systems, Inc., established in 1989, specializes in developing and marketing innovative medical technologies for treating peripheral and coronary artery diseases. The company's primary product line is its orbital atherectomy systems, which employ a diamond-coated crown to remove plaque from arteries above and below the knee. These catheter-based platforms are designed to tackle challenging disease states, including calcium buildup, which is particularly prevalent in peripheral artery disease (PAD) and coronary artery disease (CAD). Cardiovascular Systems generates most of its revenue through sales of these peripheral orbital atherectomy systems in the United States.

Promedior, Inc. is a clinical-stage biotechnology company based in Lexington, Massachusetts, focused on developing innovative therapeutics for rare fibrotic diseases and retinal fibrovascular conditions. The company targets conditions such as myelofibrosis, idiopathic pulmonary fibrosis, age-related macular degeneration, and diabetic retinopathy. Promedior's portfolio includes PRM-151, a recombinant form of human pentaxin-2 protein designed for intravenous injection, and PRM-167, a variant formulated for intravitreal delivery. Promedior employs a novel drug discovery platform that aims to regulate monocyte-derived cell populations, which are critical in inflammatory, fibrotic, and autoimmune diseases. By specifically addressing these cells at the injury site, Promedior seeks to treat the underlying causes of immune system dysregulation, promote tissue healing, and minimize systemic side effects associated with traditional therapies. The company's commitment to addressing severe and challenging conditions positions it as a significant player in the biopharmaceutical landscape.

IGA Worldwide is a leading provider of in-game advertising technology, specializing in creating impactful advertising experiences within video games. The company operates its proprietary ad serving network, Radial, which offers extensive reach and accountability across major gaming platforms, including PlayStation, PC, Nintendo Wii, and Xbox 360. IGA Worldwide focuses on delivering innovative advertising solutions, such as product placements and branded content, that enhance gameplay without being intrusive. By leveraging its expertise and advanced metrics, the company enables advertisers, developers, and publishers to effectively engage with diverse consumer audiences while they play, positioning itself as a key player in the in-game advertising sector.

Sonics is a leading innovator in network-on-chip (NoC) technology, providing a comprehensive portfolio of intelligent on-chip communication solutions tailored for home entertainment, wireless, networking, and mobile devices. Established in 1996 and headquartered in Milpitas, California, the company specializes in streamlining complex, high-speed system-on-chip (SoC) designs by addressing memory bottlenecks and enhancing data flow within embedded systems featuring multiple cores. Sonics' silicon-proven intellectual property enables designers to create heterogeneous, multi-core SoC designs that incorporate essential subsystems for security, power, and memory, ultimately delivering high performance and energy efficiency. With its solutions, Sonics has facilitated the shipment of over 750 million units globally, solidifying its position as a vital contributor to the embedded market.

Bluebird Bio is a clinical-stage biotechnology company focused on developing gene therapies to treat severe genetic and rare diseases. Its proprietary lentiviral vector platform enables the creation of potentially curative treatments by genetically modifying patients' cells to address the root cause of these conditions.

Sonics is a leading innovator in network-on-chip (NoC) technology, providing a comprehensive portfolio of intelligent on-chip communication solutions tailored for home entertainment, wireless, networking, and mobile devices. Established in 1996 and headquartered in Milpitas, California, the company specializes in streamlining complex, high-speed system-on-chip (SoC) designs by addressing memory bottlenecks and enhancing data flow within embedded systems featuring multiple cores. Sonics' silicon-proven intellectual property enables designers to create heterogeneous, multi-core SoC designs that incorporate essential subsystems for security, power, and memory, ultimately delivering high performance and energy efficiency. With its solutions, Sonics has facilitated the shipment of over 750 million units globally, solidifying its position as a vital contributor to the embedded market.

CombinatoRx is a biotech company that develops medicines from synergistic combinations of approved drugs. The company has pushed into Phase 2 clinical trials a portfolio of drug candidates aimed at cancer and multiple immuno-inflammatory diseases. CombinatoRx Service Business was acquired by Horizon Discovery Group.

TransMolecular, Inc. is a neuroscience biotechnology company dedicated to discovering, developing, and commercializing innovative drugs aimed at diagnosing and treating central nervous system diseases, particularly focusing on cancer and pain management. Founded in July 1996 and based in Birmingham, Alabama, the company has established robust technology platforms that enhance its product discovery and development pipeline. TransMolecular has received significant funding through private placements and Small Business Incentive Research grants from the National Institutes of Health, totaling $1 million for its cancer and pain programs. The company holds over 25 patents and has exclusive licensing agreements with the University of Alabama at Birmingham Research Foundation and Yale University for its specialized technologies. Its management team, boasting more than 75 years of combined experience in healthcare, pharmaceutical development, and research, is committed to advancing safe and effective therapeutic solutions for patients with limited treatment options.

Zalicus Inc. is a biopharmaceutical company based in Cambridge, Massachusetts, focused on the development of drug candidates aimed at treating pain and inflammation. The company specializes in ion-channel modulation, using its expertise to discover therapeutics that may effectively block ion channels in neuronal cells responsible for pain signal transmission. Zalicus has invested significantly in its drug discovery technology, as well as the research and development of its product candidates, which includes conducting preclinical and clinical trials. The company has also sought intellectual property protection for its innovative technologies. Its notable achievement includes the approval of Exalgo, an extended-release formulation of hydromorphone for managing moderate to severe pain in opioid-tolerant patients, granted by the United States Food and Drug Administration in 2010. Additionally, Zalicus merged with Neuromed Pharmaceuticals in 2009, further expanding its capabilities in pain management therapies.

Conor MedSystems specializes in the development of controlled drug delivery technologies for vascular applications, primarily focusing on drug-eluting stents designed to treat coronary artery disease and restenosis. The company aims to enhance the effectiveness of vascular stents by incorporating mechanisms that allow for localized drug delivery to both coronary and peripheral vessels. Through its innovative approach, Conor MedSystems seeks to improve patient outcomes in the management of vascular conditions.

Renovis, Inc. is a biopharmaceutical company focused on developing innovative drugs for neurological diseases and disorders. The company is actively engaged in creating treatments for acute ischemic stroke, neuropathic pain, and acute post-operative pain. Utilizing advanced techniques in molecular biology, medicinal chemistry, and pharmacology, Renovis identifies and selects small molecule drug candidates that adhere to rigorous development standards. Through a combination of in vitro and in vivo studies, drug metabolism and pharmacokinetics assessments, and toxicological evaluations, Renovis aims to deliver effective therapeutic solutions to address significant unmet medical needs in neurology.

Acorda Therapeutics is a biopharmaceutical company focused on developing and commercializing therapies for neurological disorders. Founded in 1995 and headquartered in Ardsley, New York, the company markets Ampyra (dalfampridine), an oral drug approved by the FDA to improve walking in patients with multiple sclerosis (MS). In Europe, this drug is marketed as Fampyra. Acorda also markets Selincro for alcohol dependence in Europe and Zanaflex Capsules for spasticity management. Additionally, the company develops Inbrija for treating OFF periods in Parkinson’s disease and ARCUS for acute migraine. Other pipeline products include rHIgM22 for MS and Cimaglermin alfa for heart failure. Acorda has collaborations with Biogen Inc. for Ampyra's development and commercialization.

Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California. The company specializes in developing innovative treatments for hemophilia and other rare bleeding disorders, utilizing its engineered subcutaneous coagulation factors to promote blood clotting. This approach aims to address the inherent limitations of traditional intravenous treatments and improve patient outcomes. Catalyst's product portfolio includes Marzeptacog alfa (activated), an advanced coagulation Factor VIIa that has completed Phase II development for hemophilia A or B with inhibitors, and Dalcinonacog alfa, a next-generation Factor IX therapy that has finished Phase IIb clinical trials for hemophilia B. Additionally, the company is working on CB 2679d-GT, an early-stage gene therapy for hemophilia B, as well as other treatments targeting dry age-related macular degeneration and systemic complement inhibitors. Catalyst Biosciences has also formed strategic collaborations with Mosaic Biosciences and Biogen to enhance its research and development efforts in these therapeutic areas. The company was founded in 2002 and has a commitment to addressing unmet medical needs in coagulation and complement disorders.

Conor MedSystems specializes in the development of controlled drug delivery technologies for vascular applications, primarily focusing on drug-eluting stents designed to treat coronary artery disease and restenosis. The company aims to enhance the effectiveness of vascular stents by incorporating mechanisms that allow for localized drug delivery to both coronary and peripheral vessels. Through its innovative approach, Conor MedSystems seeks to improve patient outcomes in the management of vascular conditions.

Sonics is a leading innovator in network-on-chip (NoC) technology, providing a comprehensive portfolio of intelligent on-chip communication solutions tailored for home entertainment, wireless, networking, and mobile devices. Established in 1996 and headquartered in Milpitas, California, the company specializes in streamlining complex, high-speed system-on-chip (SoC) designs by addressing memory bottlenecks and enhancing data flow within embedded systems featuring multiple cores. Sonics' silicon-proven intellectual property enables designers to create heterogeneous, multi-core SoC designs that incorporate essential subsystems for security, power, and memory, ultimately delivering high performance and energy efficiency. With its solutions, Sonics has facilitated the shipment of over 750 million units globally, solidifying its position as a vital contributor to the embedded market.

ModelWire is a leading provider of software solutions tailored for the modeling and fashion industry. The company enables model and talent agents to digitally advertise and book their clients efficiently. ModelWire's platform offers a comprehensive suite of tools that facilitate various aspects of agency operations, including imaging, packaging, online booking, and invoicing, ensuring that agents can manage their workflows effectively at all times. Its client base includes advertising agencies, photographers, catalog publishers, and magazines, highlighting its integral role in the industry. ModelWire operates as a subsidiary of Geyser Technologies, reinforcing its commitment to delivering innovative solutions that enhance productivity and success in the modeling sector.

Worldo, a vertical industry portal for commercial architectural interiors.

Jarg Corporation is a technology company based in Waltham, Massachusetts, founded in 1997. It specializes in developing advanced search engine technologies that enhance information retrieval by embedding search terms within context, resulting in more qualitative search results. The company’s Semantic Knowledge Indexing Platform is designed for licensing to software developers, enabling the creation of knowledge discovery applications. Jarg's distributed indexing platform is tailored to leverage graph-based data and semantic content, allowing for precise matching and improved productivity for knowledge workers. With over fifteen years of research and development in information retrieval, Jarg Corporation's solutions can be applied across various forms of digital content at an Internet scale, providing businesses with a competitive advantage in their operations.